Chronic Kidney Disease Trial, Recruiting (NCT06306963)

Chronic Kidney Disease Trial, Recruiting NCT06306963 Sponsor: Mayo Clinic Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06306963 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be older than 18 years of age
You must have been diagnosed with Gastric Antral Vascular Ectasia (a condition affecting blood vessels in the stomach), confirmed by a camera examination of the stomach (endoscopy)
You must be willing to take part in the study
You must be able to understand and sign a consent form agreeing to participate
Your symptoms must not be explained by other underlying conditions (such as diabetes) based on standard tests

Who may not be able to join:

People who regularly need blood transfusions due to ongoing blood loss
People with severe liver disease that is not well controlled
People with end-stage kidney disease (very advanced kidney failure)
People who have another condition (structural or related to body chemistry) that could affect the study results (confirm with trial site)
Women who are pregnant or currently breastfeeding
People who have not had a full blood count (a standard blood test) done within the last six months
People who currently drink heavily on a regular basis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiao Jing Wang, MD, Mayo Clinic

Phone: 507-538-9959

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06306963

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 507-538-9959

More information: https://clinicaltrials.gov/study/NCT06306963

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be older than 18 years of age
You must have been diagnosed with Gastric Antral Vascular Ectasia (a condition affecting blood vessels in the stomach), confirmed by a camera examination of the stomach (endoscopy)
You must be willing to take part in the study
You must be able to understand and sign a consent form agreeing to participate
Your symptoms must not be explained by other underlying conditions (such as diabetes) based on standard tests

Who may not be able to join:

People who regularly need blood transfusions due to ongoing blood loss
People with severe liver disease that is not well controlled
People with end-stage kidney disease (very advanced kidney failure)
People who have another condition (structural or related to body chemistry) that could affect the study results (confirm with trial site)
Women who are pregnant or currently breastfeeding
People who have not had a full blood count (a standard blood test) done within the last six months
People who currently drink heavily on a regular basis

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

22 March 2024

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Nepean Dyspepsia Index; Abridged Bowel Disease Questionnaire; Leuven Postprandial Distress Scale; Bowel Disease Screen Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov